A Stronger Reversal Effect of the Combination of Dasatinib and Menadione on P-Gp-Mediated Multidrug Resistance in Human Leukemia K562/Adr Cell Line

RSC Advances - United Kingdom
doi 10.1039/c6ra27999f
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Royal Society of Chemistry (RSC)

Related search

Reversal Effect of Arsenic Sensitivity in Human Leukemia Cell Line K562 and K562/Adm Using Realgar Transforming Solution

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
2013English

Retraction: Reversal Effect of ST6GAL 1 on Multidrug Resistance in Human Leukemia by Regulating the PI3K/Akt Pathway and the Expression of P-Gp and MRP1

PLoS ONE
Multidisciplinary
2019English

Synergistic Effects of Verapamil and Anti-Mdr1 Ribozyme on Reversion of Multidrug Resistance in the P-Glycoprotein-Positive K562 Cell Line

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2001English

Expression of P‑gp in Acute Myeloid Leukemia and the Reversal Function of As2O3 on Drug Resistance

Oncology Letters
Cancer ResearchOncology
2014English

Modifying the Sugar Moieties of Daunorubicin Overcomes P-Gp-Mediated Multidrug Resistance

Molecular Pharmaceutics
Drug DiscoveryMolecular MedicinePharmaceutical Science
2007English

Synergistic Effect of HMGB1 Knockdown and Cordycepin in the K562 Human Chronic Myeloid Leukemia Cell Line

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2015English

A Dep-Based Lab-On-A-Chip System for the Detection of Multidrug Resistance in K562 Leukemia Cells

2016English

Snail-Induced Epithelial-To-Mesenchymal Transition Enhances P-Gp-Mediated Multidrug Resistance in HCC827 Cells

Journal of Pharmaceutical Sciences
Pharmaceutical Science
2017English

Cytotoxic Effects of Some Flavonoids and Imatinib on the K562 Chronic Myeloid Leukemia Cell Line: Data Analysis Using the Combination Index Method

Balkan Medical Journal
Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy